| Product Name | Risankizumab (Synonyms: Risankizumab rzaa; BI 655066; ABBV-066) |
|---|---|
| CAS | 1612838-76-2 |
| MW | 145.92 kDa |
| Appearance | Colorless to light yellow liquid |
Risankizumab (BI 655066) is a humanised IgG monoclonal antibody, targeting IL-23 p19 subunit (Kd <10 pM) and inhibiting IL-17 production induced by human IL-23 in mouse splenocytes (IC50 = 2 pM). Risankizumab can be used to research immunological and inflammatory disorders such as psoriasis vulgaris, psoriatic arthritis, generalized pustular psoriasis and erythrodermic psoriasis.
© Copyright 2015-2026 Chemleader Biomedical Co., Ltd. All Rights Reserved.
沪ICP备15046197号-4
沪公网安备31011502007856号
Designed by Kuanersoft